Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04756245 · ClinicalTrials.gov registry record · NA

The VESPA Pilot Study

A NA study of Exercise and Loneliness, sponsored by Wake Forest University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT04756245: Recruiting NA study of Exercise and Loneliness, sponsored by Wake Forest University.

NCT04756245 is a NA study of Exercise and Loneliness that is actively recruiting participants, run by Wake Forest University. The registered enrollment target is 30 participants, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04756245, a NA study of Exercise and Loneliness, is actively recruiting participants, sponsored by Wake Forest University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Physical activity has been described by the US federal government as a 'best buy' for public health. Unfortunately, most adults in the United States are not sufficiently active, and this worsens with age. Low levels of participation are driven by many challenging barriers, including lack of access, few opportunities for enjoyable activity, and few supportive social relationships, which is especially important given the central role of social connection for lasting behavior change. A half-century of research in behavioral sciences has generated effective group-based physical activity programs, but these are inaccessible to most as they are often delivered in a few select research centers. Recent advances in telehealth have offered media for extending these interventions more broadly, but the experience of such programs is often hampered by technology that does not allow for a sense of physical and social presence. Fortunately, uptake of virtual reality (VR) is increasing rapidly, and the medium has a high level of potential for advancing the delivery of immersive evidence-based group interventions to those that most need it. Thus our specific aims are: Specific aim 1: To test the feasibility and acceptability of a group-mediated physical activity intervention delivered fully via modern VR to older adults. Specific aim 2: To examine the impact of this program on overall physical activity among older adults compared to the current standard-of-care for telehealth: the video conference meeting platform.

Primary Outcome

Feasibility will be assessed based on percentage of individuals attending all one-on-one and group calls

Interventions

  • BEHAVIORAL Virtual Reality
  • BEHAVIORAL Video Conference

Study Locations (1)

North Carolina

  • Wake Forest University - Winston-Salem

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-12-17
Est. Completion 2026-12-30
Phase NA
Wake Forest University

100 total trials

What NCT04756245 shows while recruiting

NCT04756245 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 8,910-participant average among 57 other Exercise trials with a reported enrollment target (100% lower).

The record links to 4 conditions, with Exercise appearing as the primary indexed condition, and to 2 interventions - of which Virtual Reality is the first listed.

NCT04756245 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT04756245 about?

NCT04756245 is a clinical study titled "The VESPA Pilot Study". Physical activity has been described by the US federal government as a 'best buy' for public health. Unfortunately, most adults in the United States are not sufficiently active, and this worsens with age. Low levels of participation are driven by many challenging barriers, including lack of access, ...

What is the current status of trial NCT04756245?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2020-12-17. Estimated completion is 2026-12-30.

What conditions does trial NCT04756245 study?

This clinical trial studies the following conditions: Exercise, Loneliness, Social Isolation, Behavior.

What interventions are being tested in trial NCT04756245?

The interventions under investigation include: Virtual Reality (BEHAVIORAL), Video Conference (BEHAVIORAL).

Who is sponsoring clinical trial NCT04756245?

This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04756245 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Exercise

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04756245's enrollment target sits among peer trials

30 45th of 57 higher than 12 of 57 other Exercise trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Exercise trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04756245, the US trial registry maintained by the National Library of Medicine. NCT04756245 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.